Measuring movement disorders in antipsychotic drug trials: the need to define a new standard

J Clin Psychopharmacol. 2007 Oct;27(5):423-30. doi: 10.1097/jcp.0b013e31814f1105.
No abstract available

Publication types

  • Editorial
  • Historical Article
  • Review

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / history
  • Controlled Clinical Trials as Topic
  • Dyskinesia, Drug-Induced / etiology*
  • Endpoint Determination
  • History, 20th Century
  • Humans
  • Mental Disorders / drug therapy
  • Neurologic Examination / methods*
  • Neurologic Examination / standards
  • Reference Values

Substances

  • Antipsychotic Agents